Literature DB >> 25415958

Advanced heart failure therapies for patients with chemotherapy-induced cardiomyopathy.

Guilherme H Oliveira1, Marwan Y Qattan2, Sadeer Al-Kindi2, Soon J Park2.   

Abstract

Entities:  

Keywords:  anthracyclines; cardiac resynchronization therapy; heart failure; heart transplantation

Mesh：

Substances：

Year:  2014        PMID： 25415958     DOI： 10.1161/CIRCHEARTFAILURE.114.001292

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  15 in total

Review 1.  Transplantation for chemotherapy-induced cardiomyopathy-case series and review of current practice.

Authors:  Komarakshi Rajagopalan Balakrishnan; Kemundel Genny Suresh Rao; Ganapathy Subramaniam; Dhruva Sharma
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-08-20

Review 2.  Left Ventricular Dysfunction and Chemotherapeutic Agents.

Authors:  Suparna C Clasen; Joyce W Wald
Journal:  Curr Cardiol Rep       Date:  2018-03-08       Impact factor: 2.931

3.  Management of Advanced Heart Failure due to Cancer Therapy: the Present Role of Mechanical Circulatory Support and Cardiac Transplantation.

Authors:  Salil V Deo; Sadeer G Al-Kindi; Guilherme H Oliveira
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-06

Review 4.  Heart transplantation in survivors of childhood cancer.

Authors:  Svetlana B Shugh; Thomas D Ryan
Journal:  Transl Pediatr       Date:  2019-10

5.  An epicardial delivery of nitroglycerine by active hydraulic ventricular support drug delivery system improves cardiac function in a rat model.

Authors:  Xue Li; Reyaj Mikrani; Cunyu Li; Muhammad Naveed; Ziwei Liu; Muhammad Abbas; Yijie Cheng; Lei Han; Zhijie Wang; Xiaohui Zhou
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

6.  Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapy.

Authors:  Wilson Nadruz; Erin West; Morten Sengeløv; Gabriela L Grove; Mário Santos; John D Groarke; Daniel E Forman; Brian Claggett; Hicham Skali; Anju Nohria; Amil M Shah
Journal:  Heart       Date:  2018-05-15       Impact factor: 5.994

7.  Circulating microRNAs: Potential Markers of Cardiotoxicity in Children and Young Adults Treated With Anthracycline Chemotherapy.

Authors:  Kasey J Leger; David Leonard; Danelle Nielson; James A de Lemos; Pradeep P A Mammen; Naomi J Winick
Journal:  J Am Heart Assoc       Date:  2017-04-04       Impact factor: 5.501

8.  Is it possible to prevent chemotherapy-induced heart failure with cardiovascular drugs - the review of the current clinical evidence.

Authors:  Katarzyna Korzeniowska; Jerzy Jankowski; Artur Cieślewicz; Anna Jabłecka
Journal:  Ther Clin Risk Manag       Date:  2019-09-09       Impact factor: 2.423

Review 9.  Orthotopic Heart Transplantation and Mechanical Circulatory Support in Cancer Survivors: Challenges and Outcomes.

Authors:  Nina Ghosh; John Hilton
Journal:  J Oncol       Date:  2015-08-03       Impact factor: 4.375

10.  Subcutaneous Ehrlich Ascites Carcinoma mice model for studying cancer-induced cardiomyopathy.

Authors:  Sneha Mishra; Ankit Kumar Tamta; Mohsen Sarikhani; Perumal Arumugam Desingu; Shruti M Kizkekra; Anwit Shriniwas Pandit; Shweta Kumar; Danish Khan; Sathees C Raghavan; Nagalingam R Sundaresan
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.